Downregulation of X-linked inhibitor of apoptosis protein by ‘7-Benzylidenenaltrexone maleate’ sensitizes pancreatic cancer cells to TRAIL-induced apoptosis. This evidence concerns the gene TNFSF10 and familial pancreatic carcinoma.